ATE538779T1 - Menthol-enthaltendes präparat - Google Patents
Menthol-enthaltendes präparatInfo
- Publication number
- ATE538779T1 ATE538779T1 AT04746565T AT04746565T ATE538779T1 AT E538779 T1 ATE538779 T1 AT E538779T1 AT 04746565 T AT04746565 T AT 04746565T AT 04746565 T AT04746565 T AT 04746565T AT E538779 T1 ATE538779 T1 AT E538779T1
- Authority
- AT
- Austria
- Prior art keywords
- menthol
- formulation
- digestive tract
- contraction
- long time
- Prior art date
Links
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 title abstract 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 title 1
- 229940041616 menthol Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 4
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 230000008602 contraction Effects 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000016160 smooth muscle contraction Effects 0.000 abstract 2
- 239000002518 antifoaming agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 238000001839 endoscopy Methods 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 238000005187 foaming Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000002572 peristaltic effect Effects 0.000 abstract 1
- 238000002834 transmittance Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
- A61B1/2736—Gastroscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003186493 | 2003-06-30 | ||
| PCT/JP2004/009096 WO2005000361A1 (ja) | 2003-06-30 | 2004-06-28 | メントール含有製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE538779T1 true ATE538779T1 (de) | 2012-01-15 |
Family
ID=33549692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04746565T ATE538779T1 (de) | 2003-06-30 | 2004-06-28 | Menthol-enthaltendes präparat |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20060121067A1 (de) |
| EP (2) | EP1640022B1 (de) |
| JP (1) | JP4459167B2 (de) |
| KR (1) | KR100985131B1 (de) |
| CN (2) | CN102038963B (de) |
| AT (1) | ATE538779T1 (de) |
| ES (2) | ES2379876T3 (de) |
| WO (1) | WO2005000361A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10441766B2 (en) * | 2007-08-08 | 2019-10-15 | Given Imaging Ltd. | Method for clearing a body lumen environment |
| US20090275795A1 (en) * | 2008-05-02 | 2009-11-05 | Zassi Medical Evolutions, Inc. | Continent ostomy system with chemical neuromuscular control |
| MX363963B (es) * | 2013-02-01 | 2019-04-09 | Ddrops Company | Composiciones de mentol liquidas. |
| TWI820051B (zh) * | 2017-11-01 | 2023-11-01 | 日商武田藥品工業股份有限公司 | 醫藥組合物、醫藥組合物之安定化方法、及評價醫藥組合物之保存安定性之方法 |
| CN108143717A (zh) * | 2018-02-12 | 2018-06-12 | 周基清 | 一种薄荷脑纳米乳剂及其制备方法 |
| CN109011720B (zh) * | 2018-08-27 | 2020-10-02 | 南通市晗泰化工有限公司 | 一种污水处理用高效消泡剂及其制备方法和应用 |
| CN110327471B (zh) * | 2019-01-24 | 2021-08-27 | 奥纳斯(北京)医药科技有限公司 | 一种内镜检查解痉消泡剂及其制备方法 |
| CN110200906B (zh) * | 2019-07-25 | 2021-07-20 | 奥纳斯(北京)医药科技有限公司 | 一种l-薄荷醇水溶液及其制备方法 |
| US11622944B2 (en) | 2020-01-31 | 2023-04-11 | Babak Ghalili | Stabilized menthol and other volatile compound compositions and methods |
| CN117883380B (zh) * | 2023-12-18 | 2025-04-01 | 首都医科大学附属北京同仁医院 | 一种用于治疗干眼症的经皮给药的乳剂 |
| WO2025220027A1 (en) * | 2024-04-19 | 2025-10-23 | Anikhindi Dr Shrihari | A combination liquid solution for pre-endoscopy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3422189A (en) * | 1959-01-02 | 1969-01-14 | Moraine Products | Method and compositions for the treatment of gastro-intestinal disorders |
| GB2006011B (en) * | 1977-08-04 | 1982-04-21 | Rhodes J | Carminative preparations containing essential oila their active components |
| IT1243439B (it) * | 1990-10-10 | 1994-06-10 | Pulitzer Italiana | Derivato di mentolo ad azione spasmolitica |
| JP3286350B2 (ja) * | 1992-08-07 | 2002-05-27 | 花王株式会社 | 透明水性組成物 |
| MXPA02005771A (es) * | 1995-06-05 | 2005-02-22 | Whitehill Oral Tech Inc | Productos basados en ultraemulsion para el cuidado oral. |
| JP3524717B2 (ja) * | 1997-06-13 | 2004-05-10 | 株式会社資生堂 | 油中水型乳化組成物及びこれを用いた乳化化粧料 |
| US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| AU2002343555A1 (en) * | 2001-11-14 | 2003-05-26 | Texas Tech University | Eutectic-based self-nanoemulsified drug delivery system |
| JP2003292450A (ja) * | 2002-02-01 | 2003-10-15 | Naoki Hiki | 胃蠕動抑制剤 |
| JP4526120B2 (ja) * | 2002-05-22 | 2010-08-18 | 日本製薬株式会社 | Ｌ−メントール水中油型乳剤 |
| WO2003097026A1 (en) * | 2002-05-22 | 2003-11-27 | Nihon Pharmaceutical Co., Ltd. | Smooth muscle peristole inhibitor |
| US6897195B2 (en) * | 2002-07-24 | 2005-05-24 | Nanjing Zhongshi Chemical Co. | Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent |
-
2004
- 2004-06-28 JP JP2005511070A patent/JP4459167B2/ja not_active Expired - Lifetime
- 2004-06-28 ES ES04746565T patent/ES2379876T3/es not_active Expired - Lifetime
- 2004-06-28 CN CN2010106116906A patent/CN102038963B/zh not_active Expired - Lifetime
- 2004-06-28 WO PCT/JP2004/009096 patent/WO2005000361A1/ja not_active Ceased
- 2004-06-28 AT AT04746565T patent/ATE538779T1/de active
- 2004-06-28 EP EP04746565A patent/EP1640022B1/de not_active Expired - Lifetime
- 2004-06-28 ES ES11151652T patent/ES2390162T3/es not_active Expired - Lifetime
- 2004-06-28 CN CN2004800185892A patent/CN1893982B/zh not_active Expired - Lifetime
- 2004-06-28 KR KR1020057025392A patent/KR100985131B1/ko not_active Expired - Lifetime
- 2004-06-28 EP EP11151652A patent/EP2311444B1/de not_active Expired - Lifetime
- 2004-06-28 US US10/559,731 patent/US20060121067A1/en not_active Abandoned
-
2009
- 2009-07-27 US US12/458,876 patent/US7993635B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2390162T3 (es) | 2012-11-07 |
| EP2311444B1 (de) | 2012-06-27 |
| EP2311444A1 (de) | 2011-04-20 |
| HK1155640A1 (en) | 2012-05-25 |
| US20090292028A1 (en) | 2009-11-26 |
| JPWO2005000361A1 (ja) | 2006-10-19 |
| CN102038963B (zh) | 2013-09-11 |
| HK1098683A1 (en) | 2007-07-27 |
| EP1640022B1 (de) | 2011-12-28 |
| EP1640022A1 (de) | 2006-03-29 |
| ES2379876T3 (es) | 2012-05-04 |
| KR100985131B1 (ko) | 2010-10-05 |
| CN1893982B (zh) | 2013-02-13 |
| US7993635B2 (en) | 2011-08-09 |
| JP4459167B2 (ja) | 2010-04-28 |
| KR20060032604A (ko) | 2006-04-17 |
| CN102038963A (zh) | 2011-05-04 |
| US20060121067A1 (en) | 2006-06-08 |
| WO2005000361A1 (ja) | 2005-01-06 |
| EP1640022A4 (de) | 2008-08-06 |
| CN1893982A (zh) | 2007-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104981253B (zh) | 固溶体组合物及其在慢性炎症中的用途 | |
| ATE538779T1 (de) | Menthol-enthaltendes präparat | |
| Sirak et al. | Clinical and morphological substantiation of treatment of odontogenic cysts of the maxilla | |
| EA200701519A1 (ru) | Живая аттенуированная ротавирусная вакцина для перорального введения | |
| WO2006041942A3 (en) | Ocular delivery of polymeric delivery formulations | |
| WO2006094737A8 (en) | Gastroresistant pharmaceutical formulations containing rifaximin | |
| WO2007084247A3 (en) | Stable therapeutic formulations | |
| JP2019501108A5 (de) | ||
| WO2004019921A3 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
| AU2015213577A2 (en) | Halogen treatment of heart attack and ischemic injury | |
| JP2016512210A5 (de) | ||
| ES2402907T3 (es) | Roscovitina para el tratamiento de ciertas enfermedades quísticas | |
| WO2006081363A3 (en) | Oral formulations for delivery of catecholic butanes including ndga compounds | |
| MY199546A (en) | Stable protein compositions | |
| SE0402925D0 (sv) | Novel Compounds | |
| WO2006138608A3 (en) | Pharmaceutical compositions and use thereof | |
| Moraes et al. | Liquid nitrogen cryosurgery for treatment of mucoceles in children | |
| EA200602016A1 (ru) | ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ | |
| WO2008157369A3 (en) | Use of taci-ig fusion protein such as atacicept for the manufacture of a medicament for treating lupus erythematosus | |
| EP3570847A1 (de) | Zusammensetzungen zur polypanhebung und verfahren zur verwendung | |
| NO20021437D0 (no) | Fremgangsmate til forebyggelse av kolorektal kreft | |
| EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
| RU2016127361A (ru) | Гастроретентивные фармацевтические композиции для перорального введения | |
| Koizumi et al. | Angiomyolipoma of the tongue | |
| TW200509945A (en) | Agent for treatment of anal disease |